Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN53,5653,59-0,28
Msft0,35
Nokia4,1424,29958,48
IBM-0,29
Mercedes-Benz Group AG57,3557,360,70
PFE-0,17
19.10.2024 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 18.10.2024 22:00:00
Fortinet (FTNT.O, NASDAQ Cons)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (ks)
81,07 0,26 0,21 2 885 170
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 19.10.2024
Popis společnosti

Business Summary: Fortinet, Inc. provides an integrated platform, the Fortinet Security Fabric, that spans networking, unified Secure Access Service Edge (SASE) and AI-driven security operations to deliver cybersecurity where customers need it. It offers solutions to enterprises, such as in the financial services, retail and operational technology market verticals, communication and security service providers, government organizations and small and medium-sized businesses. Its Secure Networking solutions focuses on the convergence of networking and security via its network firewall and its switches, access points and other secure connectivity solutions. Its Unified SASE solution is a single-vendor SASE solution that includes Firewall, SD-WAN, Secure Web Gateway, Cloud Access Services Broker, and Data Loss Prevention, Zero Trust Network Access and cloud security. Its Security Operations solutions are delivered as a platform that automates detection and response to accelerate discovery and remediation.
Financial Summary: BRIEF: For the six months ended 30 June 2024, Fortinet Inc revenues increased 9% to $2.79B. Net income increased 32% to $679.1M. Revenues reflect Security subscription - FortiGuard segment increase of 25% to $1.1B, Technical support - FortiCare segment increase of 18% to $831.2M, Europe, Middle East and Africa (“EMEA”) segment increase of 12% to $1.1B, United States segment increase of 7% to $842.8M.



  • Poslední aktualizace: 19.10.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive Officer, Co-Founder, DirectorAndre Choulika5901.01.2000
Deputy Chief Executive Officer, Co-Founder, Executive Vice President - CMC and Manufacturing, DirectorDavid Sourdive5701.01.2008
Interim Chief Financial OfficerArthur Stril3502.05.2024
Chief Human Resource Officer, Executive Vice PresidentKyung Nam-Wortman5416.11.2020
Senior Vice President - US ManufacturingSteven Doares6421.07.2020
Chief Scientific OfficerPhilippe Duchateau6101.01.2004
Chief Regulatory and Pharmaceutical Compliance OfficerStephan Reynier55
General CounselMarie-Bleuenn Terrier4201.01.2013
Chief Medical OfficerAdrian Kilcoyne-07.08.202407.08.2024